TRX103
Near Add Your Location
Accepting patients
TRX-103
Phase I, First in Human, Open Label Study to Evaluate Safety and Tolerability of TRX103 Cells in Subjects With Hematological Malignancies Undergoing HLA-mismatched Related or Unrelated Hematopoietic Stem Cell Transplantation (HSCT)
- T Cell (Allogeneic)
- Phase 1
Showing 1-1 of 1